Literature DB >> 23102905

Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia-reperfusion: relationship to interstitial microRNA dynamics and myocardial function.

Shaina R Eckhouse1, Adam W Akerman, Christina B Logdon, J Marshall Oelsen, Elizabeth C O'Quinn, Elizabeth K Nadeau, Robert E Stroud, Rupak Mukherjee, Jeffrey A Jones, Francis G Spinale.   

Abstract

OBJECTIVES: Membrane type 1 matrix metalloproteinase (MT1-MMP) is critical to a number of proteolytic and profibrotic events. However, upstream regulation of MT1-MMP with myocardial ischemia-reperfusion remains poorly understood. MicroRNAs regulate post-transcriptional events, and in silico mapping has identified a conserved sequence in MT1-MMP for microRNA-133a. This study tested the hypothesis that changes in microRNA-133a regulation occur with myocardial ischemia-reperfusion, which contributes to time- and region-dependent changes in MT1-MMP activity and processing of MT1-MMP substrates.
METHODS: Yorkshire pigs (n = 12) underwent ischemia-reperfusion (90 minutes ischemia and 120 minutes reperfusion), where regional preload recruitable stroke work (sonomicrometry), interstitial MT1-MMP activity (microdialysis), Smad2 abundance (immunoblotting), and interstitial microRNA-133a (polymerase chain reaction) were determined within the ischemia-reperfusion and remote regions. Human left ventricular fibroblasts were transduced with microRNA-133a and anti-microRNA-133a (lentivirus) to determine the effects on MT1-MMP protein abundance.
RESULTS: With ischemia-reperfusion, regional preload recruitable stroke work decreased from steady state (139 ± 20 mm Hg to 44 ± 11 mm Hg, P < .05) within the ischemia-reperfusion region. MT1-MMP activity increased in both regions. Phosphorylated Smad2 increased within the ischemia-reperfusion region. Both in vitro and in vivo interstitial levels of microRNA-133a decreased with ischemia and returned to steady-state levels with reperfusion. In vitro transduction of microRNA-133a in left ventricular fibroblasts decreased MT1-MMP levels.
CONCLUSIONS: Modulation of MT1-MMP activity and microRNA-133a exportation into the myocardial interstitium occurred in the setting of acute myocardial ischemia-reperfusion. In addition, changes in microRNA-133a expression in left ventricular fibroblasts resulted in an inverse modulation of MT1-MMP abundance. Therefore, targeting of microRNA-133a represents a potentially novel means for regulating the cascade of profibrotic events after ischemia-reperfusion. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102905      PMCID: PMC3602970          DOI: 10.1016/j.jtcvs.2012.09.071

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  43 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy.

Authors:  Laura S Spruill; Abigail S Lowry; Robert E Stroud; Christina E Squires; Ira M Mains; English C Flack; Christy Beck; John S Ikonomidis; A Jackson Crumbley; Paul J McDermott; Francis G Spinale
Journal:  Am J Physiol Cell Physiol       Date:  2007-08-01       Impact factor: 4.249

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

Review 5.  MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.

Authors:  Eva van Rooij; Eric N Olson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 6.  The inflammatory response in myocardial infarction.

Authors:  Nikolaos G Frangogiannis; C Wayne Smith; Mark L Entman
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

Review 7.  The cardiac fibroblast: therapeutic target in myocardial remodeling and failure.

Authors:  R Dale Brown; S Kelly Ambler; M Darren Mitchell; Carlin S Long
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

8.  Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1.

Authors:  Laura Fontana; Yan Chen; Petra Prijatelj; Takao Sakai; Reinhard Fässler; Lynn Y Sakai; Daniel B Rifkin
Journal:  FASEB J       Date:  2005-11       Impact factor: 5.191

Review 9.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

10.  Alterations in cultured myocardial fibroblast function following the development of left ventricular failure.

Authors:  English C Flack; Merry L Lindsey; Christina E Squires; Brooke S Kaplan; Robert E Stroud; Leslie L Clark; Patricia G Escobar; William M Yarbrough; Francis G Spinale
Journal:  J Mol Cell Cardiol       Date:  2006-03-06       Impact factor: 5.000

View more
  3 in total

Review 1.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

2.  Elevated Wall Tension Leads to Reduced miR-133a in the Thoracic Aorta by Exosome Release.

Authors:  Adam W Akerman; Walker M Blanding; Robert E Stroud; Elizabeth K Nadeau; Rupak Mukherjee; Jean Marie Ruddy; Michael R Zile; John S Ikonomidis; Jeffrey A Jones
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

Review 3.  MicroRNAs Regulating Renin-Angiotensin-Aldosterone System, Sympathetic Nervous System and Left Ventricular Hypertrophy in Systemic Arterial Hypertension.

Authors:  Alex Cleber Improta-Caria; Marcela Gordilho Aras; Luca Nascimento; Ricardo Augusto Leoni De Sousa; Roque Aras-Júnior; Bruno Solano de Freitas Souza
Journal:  Biomolecules       Date:  2021-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.